Evidence map›Paper›PMID 39989803›Full record

ArticleACS omega2025

Cannabinoids as Promising Inhibitors of HER2-Tyrosine Kinase: A Novel Strategy for Targeting HER2-Positive Ovarian Cancer.

Thomanai Lamtha, Nathjanan Jongkon, Tossaporn Lertvanithphol, Mati Horprathum, Supaphorn Seetaha, Kiattawee Choowongkomon

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. The Pharmacological Profile of Plant-Derived Cannabinoids In Vitro.Current topics in behavioral neurosciences · 2026
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Thomanai LamthaLaboratory of Protein Engineering and Bioinformatics (PROTEP), Department of Biochemistry, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand.ORCID https://orcid.org/0000-0001-5918-8704
Nathjanan JongkonDepartment of Social and Applied Science, College of Industrial Technology, King Mongkut's University of Technology North Bangkok, Bangkok 10800, Thailand.
Tossaporn LertvanithpholThe National Electronics and Computer Technology Center (NECTEC), National Science and Technology Development Agency (NSTDA), Thailand Science Park, Pathum Thani 12120, Thailand.
Mati HorprathumThe National Electronics and Computer Technology Center (NECTEC), National Science and Technology Development Agency (NSTDA), Thailand Science Park, Pathum Thani 12120, Thailand.ORCID https://orcid.org/0000-0003-1507-3555
Supaphorn SeetahaLaboratory of Protein Engineering and Bioinformatics (PROTEP), Department of Biochemistry, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand.
Kiattawee ChoowongkomonLaboratory of Protein Engineering and Bioinformatics (PROTEP), Department of Biochemistry, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand.ORCID https://orcid.org/0000-0002-2421-7859

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human epidermal growth factor receptor 2 (HER2) is a transmembrane receptor within the ErbB family that plays a pivotal role in the progression of various aggressive cancers. HER2-positive tumors often develop resistance to standard therapies, necessitating the exploration of innovative treatment options. Cannabinoids, bioactive compounds from

Identifiers

PMID39989803
PMCPMC11840771

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.